Type 1 diabetes research sheds light on biomarkers in partial remission phase

Researchers from the Germans Trias i Pujol Research Institute (IGTP) have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes in collaboration with experts in β-cell biology and regeneration from the Diabetes Research Institute in Miami. The study has been published in Trends in Endocrinology and Metabolism.